Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Bridge Treatment for Probationers and Parolees
NCT03616236Phase 3Suspended
- Sponsor
- Friends Research Institute
- Start
- Jul 2022
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by Friends Research Institute. Started Jul 2022; status: suspended.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03616236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03616236.